石四药集团(02005.HK)：45个品种拟中标国家集采接续 覆盖多治疗领域利好业务发展
SSY GROUPSSY GROUP(HK:02005) Ge Long Hui·2026-02-10 08:40

Core Viewpoint - The company, Stone Four Pharmaceutical Group, announced that it is expected to win bids for 45 products in the upcoming national centralized procurement in China, which is anticipated to positively impact its business [1] Group 1: Product Categories - The 45 products cover various therapeutic areas including anti-infection, cardiovascular system, respiratory system, digestive system, and nervous system [1]